[emn20180331ex1001amendme001.jpg]
EXECUTION VERSION 162107400 AMENDMENT NO. 13 TO AMENDED AND RESTATED RECEIVABLES
PURCHASE AGREEMENT THIS AMENDMENT NO. 13 TO AMENDED AND RESTATED RECEIVABLES
PURCHASE AGREEMENT, dated as of April 2, 2018 (this “Amendment”), amends that
certain AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT dated as of July 9,
2008 (as amended by Amendment No. 1 to Amended and Restated Receivables Purchase
Agreement dated as of September 15, 2008, Amendment No. 2 to Amended and
Restated Receivables Purchase Agreement dated as of February 18, 2009, Amendment
No. 3 to Amended and Restated Receivables Purchase Agreement dated as of July 8,
2009, Amendment No. 4 to Amended and Restated Receivables Purchase Agreement
dated as of January 29, 2010, Amendment No. 5 to Amended and Restated
Receivables Purchase Agreement dated as of July 7, 2010, Omnibus Amendment
(Amendment No. 1 to Second Amended and Restated Receivables Purchase and Sale
Agreement and Amendment No. 6 to Amended and Restated Receivables Purchase
Agreement and Partial Release) dated as of January 31, 2011, Amendment No. 7 to
Amended and Restated Receivables Purchase Agreement dated as of July 6, 2011,
Amendment No. 8 to Amended and Restated Receivables Purchase Agreement dated as
of April 30, 2012, Amendment No. 9 to Amended and Restated Receivables Purchase
Agreement dated as of August 1, 2013, Amendment No. 10 to Amended and Restated
Receivables Purchase Agreement dated as of August 29, 2014, Letter Agreement
dated as of March 16, 2015, Amendment No. 11 to Amended and Restated Receivables
Purchase Agreement dated as of July 8, 2015 and Amendment No. 12 to Amended and
Restated Receivables Purchase Agreement dated as of August 31, 2016 (as so
amended, the “Existing Agreement”, and the Existing Agreement, as amended hereby
and as it may be further amended, restated, supplemented or otherwise modified
from time to time, the “Agreement”), by and among EASTMAN CHEMICAL FINANCIAL
CORPORATION, a Delaware corporation, as Seller (in such capacity, the “Seller”)
and as initial Servicer (in such capacity, the “Initial Servicer”), VICTORY
RECEIVABLES CORPORATION (“Victory”), and MUFG BANK, LTD. (formerly known as The
Bank of Tokyo-Mitsubishi UFJ, Ltd.), as a Victory Liquidity Bank (in such
capacity, the “Victory Liquidity Bank”), Victory Agent (in such capacity, the
“Victory Agent”) and as administrative agent (in such capacity, the
“Administrative Agent”). Capitalized terms used and not otherwise defined herein
shall have the meanings given to such terms in the Agreement. RECITALS: WHEREAS,
the parties hereto are party to the Agreement, pursuant to which, from time to
time during the term thereof, the Seller may transfer and assign Receivable
Interests to the Administrative Agent for the benefit of the Purchasers, in each
case, on the terms and conditions set forth in the Agreement; and WHEREAS, the
parties hereto wish to amend the Agreement as further provided herein. NOW,
THEREFORE, for good and valuable consideration, the sufficiency of which is
hereby acknowledged, the parties hereby agree as follows: SECTION 1. AMENDMENT.
(a) Each reference to “The Bank of Tokyo-Mitsubishi UFJ Ltd., New York Branch”
in the Existing Agreement is hereby amended to read as “MUFG Bank, Ltd.
(formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.)”.

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme002.jpg]
2 162107400 (b) Each reference to “BTMU” in the Existing Agreement is hereby
amended to read as “MUFG”. (c) The definition of “Co-Agents’ Fee Letter” in
Exhibit I to the Existing Agreement is hereby amended and restated in its
entirety to read as follows: “Co-Agents’ Fee Letter” means that certain Fifth
Amended and Restated Co-Agents’ Fee Letter dated as of April 2, 2018 between the
Seller and MUFG, as amended, restated and/or otherwise modified from time to
time. (d) Sections (a) and (c) of the definition of “Concentration Limit” in
Exhibit I to the Existing Agreement is hereby amended and restated in its
entirety to read as follows: (a) for all Receivables that require payment (i)
within 66-90 days after the original invoice date therefor, an amount equal to
25% of the aggregate Outstanding Balance of all Eligible Receivables at such
time, and (ii) within 91-120 days after the original invoice date therefor, an
amount equal to 5% of the aggregate Outstanding Balance of all Eligible
Receivables at such time; (c) for all Receivables the Obligor of which, if a
natural person, is not a resident of the United States or, if a corporation or
other business organization, is either not organized under the laws of the
United States or any political subdivision thereof or does not have its chief
executive office in the United States, an amount equal to 10% of the aggregate
Outstanding Balance of all Eligible Receivables at such time; (e) A new Section
14.16 is here by added to read as follows: Intent. The intent of this Agreement
is to be utilized as a working capital line of credit and not to serve as the
primary backup to any Commercial Paper Program to refinance such Commercial
Paper Program during a time of market stress. (f) The definition of
“Concentration Limit” in Exhibit I to the Existing Agreement is hereby amended
by inserting the following new Section (d) at the end thereof: (d) for all
Receivables related to an Ocean Bill of Lading Invoice for which the actual
shipping date of the underlying goods is more than 30 days from the estimated
shipping date set forth in such Ocean Bill of Lading Invoice, and regardless of
whether the underlying goods are thereafter shipped, an amount equal to 0% of
the aggregate Outstanding Balance of all Eligible Receivables at such time. (g)
Exhibit I to the Existing Purchase Agreement is hereby amended by inserting the
following new definitions in their appropriate alphabetical order: “Commercial
Paper Program” means any program under which the Servicer or any of its
Affiliates issues commercial paper notes. “Ocean Bill of Lading Invoice” means
an Invoice with respect to which the underlying goods have not yet been shipped
and as to which such Invoice identifies that the underlying goods are estimated
to ship on an estimated shipping date (and which is thereafter updated to
reflect the actual shipping date).

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme003.jpg]
3 162107400 (h) Clause (10) of the definition of “Eligible Receivable” in
Exhibit I to the Existing Agreement is hereby amended and restated in its
entirety to read as follows: (10) a Receivable as to which any Originator has
satisfied and fully performed all obligations on its part with respect to such
Receivable required to be fulfilled by it, and no further action is required to
be performed by any Person with respect thereto other than payment thereon by
the applicable Obligor, and, in the case of a Receivable related to an Ocean
Bill of Lading Invoice and subject to the limitations set forth in clause (d) of
the definition of “Concentration Limit”, shipment of the underlying goods, (i)
The definition of “Group Limit” in Exhibit I to the Existing Agreement is hereby
amended and restated in its entirety to read as follows: “Group Limit” means
$350,000,000, unless Administrative Agent has delivered written notice to Seller
after April 2, 2019 reducing such amount to an amount not less than
$250,000,000. (j) The definition of “Liquidity Termination Date” in Exhibit I to
the Existing Agreement is hereby amended and restated in its entirety to read as
follows: “Liquidity Termination Date” means April 2, 2020. (k) The definition of
“Originator” in Exhibit I to the Existing Agreement is hereby amended and
restated in its entirety to read as follows: “Originator” means each of Eastman
Chemical Company, a Delaware corporation, Solutia Inc., a Delaware corporation,
Flexsys America L.P., a Delaware limited partnership, and Eastman Chemical Ltd.,
a New York corporation. (l) The definition of “Purchase Limit” in Exhibit I to
the Existing Agreement is hereby amended and restated in its entirety to read as
follows: “Purchase Limit” means $350,000,000, unless Administrative Agent has
delivered written notice to Seller after April 2, 2019 reducing such amount to
an amount not less than $250,000,000. (m) Exhibit V to the Existing Agreement is
hereby deleted and replaced with Exhibit V hereto. SECTION 2. REPRESENTATIONS
AND WARRANTIES. As of the date hereof, the Seller makes, for the benefit of the
Administrative Agent for the benefit of the Purchasers, the following
representations and warranties: (i) each of the representations and warranties
set forth in Section 5.1 of the Agreement (in each case, as each such
representation and warranty has been amended hereby), (ii) the Seller has the
corporate power and authority to execute, deliver and carry out the terms and
provisions of this Amendment (and the Agreement as amended by this Amendment),
(iii) the Seller has taken all necessary corporate action to authorize its
execution, delivery and performance of this Amendment (and the Agreement as
amended by this Amendment), and (iv) the Seller has duly executed and delivered
this Amendment, and each of this Amendment (and the Agreement as amended by this
Amendment) constitutes the Seller’s legal, valid and binding

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme004.jpg]
4 162107400 obligation, enforceable in accordance with the terms of each such
document, except as enforcement thereof may be subject to (x) the effect of any
applicable bankruptcy, insolvency, reorganization, moratorium or similar law
affecting creditors’ rights generally and (y) general principles of equity
(regardless of whether such enforcement is sought in a proceeding in equity or
at law). SECTION 3. CONSENT. Pursuant to Section 7.2(f) of the Agreement, the
Administrative Agent hereby consents to execution by the Seller of Amendment No.
1 to Third Amended and Restated Receivables Purchase and Sale Agreement, dated
as of the date hereof, by and among Eastman Chemical Company, Solutia Inc.,
Flexsys America L.P., Eastman Chemical Ltd. and the Seller. SECTION 4.
MISCELLANEOUS. (a) Costs and Expenses. Seller agrees to pay on demand all
reasonable costs and expenses in connection with the preparation, execution and
delivery of this Amendment, including, without limitation, the reasonable fees
and out-of-pocket expenses of counsel for the Administrative Agent with respect
thereto. (b) Counterparts. This Amendment may be executed in any number of
counterparts, and by the different parties hereto on separate counterparts; each
such counterpart shall be deemed an original and all of such counterparts taken
together shall be deemed to constitute one and the same instrument. A facsimile
or electronic copy of an executed counterpart of this Amendment shall be
effective as an original for all purposes. (c) Effect; Transaction Document.
Upon (i) the execution and delivery of this Amendment, (ii) payment by Seller to
the Victory Agent of all amounts payable under the Fifth Amended and Restated
Co-Agents’ Fee Letter entered into on the date hereof in connection herewith,
and (iii) the execution and/or delivery of each other document listed on the
closing checklist attached hereto as Schedule I in form and substance
satisfactory to the Administrative Agent, the Agreement shall be and be deemed
to be amended as set forth in this Amendment. All of the provisions of the
Agreement shall remain in full force and effect as so amended. This Amendment
shall be deemed to be a Transaction Document for all purposes (including,
without limitation, for the purposes of each of the representations and
warranties in Section 5.1 of the Agreement). (d) Governing Law. This Amendment
shall be governed by and construed in accordance with the Laws of the State of
New York without regard to the principles of conflicts of law thereof (other
than Sections 5-1401 and 5-1402 of the New York General Obligations Law). (e)
Consent to Jurisdiction. Any litigation based hereon, or arising out of, under
or in connection with this Amendment may be brought and maintained in the courts
of the State of New York sitting in New York County, New York or in the United
States district court for the Southern District of New York. (f) WAIVER OF JURY
TRIAL. EACH PARTY HERETO HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY
ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS AMENDMENT OR ANY
APPLICATION, INSTRUMENT, DOCUMENT, AMENDMENT OR AGREEMENT DELIVERED OR WHICH MAY
IN THE FUTURE BE DELIVERED IN CONNECTION

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme005.jpg]
5 162107400 HEREWITH OR ARISING FROM ANY BANKING RELATIONSHIP EXISTING IN
CONNECTION WITH THIS AMENDMENT, AND AGREES THAT ANY SUCH ACTION OR PROCEEDING
SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. [Signature page follows]

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme006.jpg]

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme007.jpg]

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme008.jpg]

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme009.jpg]
162107400 SCHEDULE I CLOSING CHECKLIST ATTACHED.

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme010.jpg]
US:145592475v7 EASTMAN 2018 AMENDMENT - CLOSING CHECKLIST Eastman Chemical
Company Seller/Parent ECC Eastman Chemical Ltd. Seller ECL Eastman Chemical
Financial Corporation SPV ECFC MUFG Bank, Ltd. (formerly known as The Bank of
Tokyo-Mitsubishi UFJ, Ltd.) Purchaser MUFG Jones Day Counsel to Eastman JD
Arnold & Porter Kaye Scholer LLP Counsel to BMTU APKS Wells Fargo Bank, National
Association Deposit Account Bank Wells DOCUMENT RESPONSIBLE PARTY
STATUS/COMMENTS MAIN TRANSACTION DOCUMENTS 1. Amendment No. 13 to Receivables
Purchase Agreement APKS Executed a. Exhibit V – Form of Monthly Report APKS 2.
Amendment No. 1 to Third Amended and Restated Receivables Purchase and Sale
Agreement APKS Executed a. Exhibit A - Conformed RPSA APKS 3. Fifth Amended and
Restated Co-Agents’ Fee Letter APKS Executed a. Exhibit A – Company Codes
Eastman CORPORATE DOCUMENTS 1. Secretary’s Certificate of ECL certifying as to
the following: a. Incumbency b. Operating Document c. Formation Document d.
Resolutions ECL Executed 2. Good Standing Certificate for: a. ECL ECL Received
OTHER DOCUMENTS & OPINIONS 1. UCC-1 Financing Statement naming ECL as APKS Final

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme011.jpg]
US:145592475v7 Debtor 2. Lien Searches for ECL APKS Received 3. Corporate
Authorization Opinion Eastman Executed 4. True Sale and Substantive
Consolidation Opinion JD Executed 5. UCC and Enforceability Opinion JD Executed
6. Note from ECFC in favor of ECL APKS Executed 7. Amendment to ECFC Certificate
of Incorporation Eastman Filed 8. Resolutions re Amendment to ECFC Certificate
of Incorporation Eastman Executed

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme012.jpg]
[Signature Page to Amendment No. 13] 162107400 EXHIBIT V FORM OF MONTHLY REPORT
ATTACHED.

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme013.jpg]
Eastman Chemical Financial Corp Monthly Servicer Report for the Month Ended: 185
All Units USD ($) Unless Noted Borrowing Base: I. Portfolio Aging Schedule ($)
(%) (%) (%) 1 Month Prior 2 Months Prior Current (Net of Unapplied Credits) #N/A
#N/A #N/A #N/A 1-30 Days Past Due #N/A #N/A #N/A #N/A 31-60 Days Past Due #N/A
#N/A #N/A #N/A 61-90 Days Past Due #N/A #N/A #N/A #N/A 91-120 Days Past Due #N/A
#N/A #N/A #N/A 121+ Days Past Due #N/A #N/A #N/A #N/A Aging Total #N/A #N/A #N/A
#N/A II. Rollforward Activity #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A #N/A
A/R Reconciliation / Difference: #N/A III. Ineligible Receivables & Net Eligible
Receivables (-) (+) Calculated Ending Rollforward Balance #N/A Defaulted
Receivables (Gross) #N/A Receivables with Terms > 65 Days #N/A Excess Extended
Terms (66-90 days)25% Carveout #N/A Excess Extended Terms (91-120 days)5%
Carveout #N/A Excess Non US Obligors LT 65 days10% Carveout #N/A Receivables of
Bankrupt Obligors #N/A Government Receivables #N/A Non-US Denominated
Receivables #N/A Receivables of Non-US Obligors #N/A Cross-Aging Receivables
#N/A Contra-Accounts #N/A Unapplied Cash #N/A Intercompany (< 90 DPD) #N/A Note
Receivable (< 90 DPD) #N/A Total Ineligible Receivables #N/A Eligible
Receivables Balance #N/A Allowance for Volume Incentives #N/A Net Eligible
Receivables #N/A IV. Excess Concentrations 1 #N/A #N/A #N/A #N/A #N/A #N/A 2
#N/A #N/A #N/A #N/A #N/A #N/A 3 #N/A #N/A #N/A #N/A #N/A #N/A 4 #N/A #N/A #N/A
#N/A #N/A #N/A 5 #N/A #N/A #N/A #N/A #N/A #N/A 6 #N/A #N/A #N/A #N/A #N/A #N/A 7
#N/A #N/A #N/A #N/A #N/A #N/A 8 #N/A #N/A #N/A #N/A #N/A #N/A 9 #N/A #N/A #N/A
#N/A #N/A #N/A 10 #N/A #N/A #N/A #N/A #N/A #N/A Total Excess Concentration #N/A
V. Excess Carveouts & Net Receivable Balance (-) (+) Net Eligible Receivables
#N/A Total Excess Concentration #N/A Extended Terms (AR 66-90 Days) #N/A
Extended Terms (AR 91-120 Days) #N/A Non US Obligors (AR LT 66 Days) #N/A Total
Excess Carveouts #N/A Net Receivable Balance #N/A #N/A Current Month Outstanding
Receivables Concentration Limit (%) Credits EOM AR Balance Misc. Adj. /
PlugCancellations Accrued Volume Incentives Rebills Beginning Balance Sales
Excess Receivables% of Total Write-Offs Obligor Code Short Term Debt Rating
Collections 1 4/2/2018 - 12:15 PM

--------------------------------------------------------------------------------

 
[emn20180331ex1001amendme014.jpg]
Eastman Chemical Financial Corp Monthly Servicer Report for the Month Ended: 185
All Units USD ($) Unless Noted VI. Reserve Calculations 1 Month Prior 2 Months
Prior LOSS RESERVE Sales (5 months prior) #NUM! #NUM! Default Proxy (91-120 DPI)
+ W/O #N/A Default Ratio (Current) #N/A Default Ratio 3M Average #N/A 12M High
of 3M Avg. Default Ratio #N/A Loss Horizon Factor #N/A Loss Percentage #N/A #N/A
#N/A Loss Reserve Amount #N/A #N/A #N/A DILUTION RESERVE Sales (1 month prior)
#NUM! #NUM! Total Dilution for Reserve #N/A Dilution Ratio (Current) #N/A
Dilution Ratio 3M Average #N/A 12M High of 3M Average Dilution Ratio #N/A
Dilution Horizon Factor #N/A Dilution Volatility Component #N/A Dilution Reserve
Percentage #N/A #N/A #N/A Dilution Reserve Amount #N/A #N/A #N/A YIELD &
SERVICING FEE RESERVE Days Sales Outstanding (DSO) #N/A 12M High DSO #N/A
Discount Reserve #N/A #N/A #N/A Servicing Reserve #N/A #N/A #N/A Yield &
Servicing Fee Reserve Amount #N/A #N/A #N/A REQUIRED RESERVES Total Dynamic
Reserve #N/A #N/A #N/A Reserve Floor #N/A #N/A #N/A Required Reserve % #N/A #N/A
#N/A Required Reserve $ (RR) #N/A #N/A #N/A VII. Borrowing Base & Funding
Availability Total A/R #N/A #N/A #N/A Less: Total Ineligibles #N/A #N/A #N/A
Eligible Receivables #N/A #N/A #N/A Less: Allowance for Vol. Incentives #N/A
#N/A #N/A Net Eligible Receivables #N/A #N/A #N/A Less: Total Excess Carveouts
#N/A #N/A #N/A Net Receivable Balance #N/A #N/A #N/A Less: Required Reserves
(RR) #N/A #N/A #N/A Borrowing Base (Available for Funding) #N/A #N/A #N/A
Facility Limit 350,000,000 Maximum Funding Amount 350,000,000 Capital
Outstanding #N/A Receivable Interest #N/A #N/A #N/A VIII. Compliance 1 Month
Prior 2 Months Prior COMPLIANCE TEST Compliance Receivable Interest: Is CP /
(NRB - RR) ≤ 100% ? #N/A #N/A #N/A #N/A Is the 3-month rolling average
Delinquency Ratio less than 1.35% ? #N/A #N/A #N/A #N/A Is the 3-month rolling
average Default Ratio less than 1.35% ? #N/A #N/A #N/A #N/A Is the 3-month
rolling average Dilution Ratio less than 4% ? #N/A #N/A #N/A #N/A Signature:
Date: Name (print): H. Keith Jennings Title: Eastman Chemical Financial
Corporation and warranties related to such Agreement are restated and
reaffirmed. The undersigned hereby represents and warrants that the foregoing is
a true and accurate accounting with respect to outstanding receivables as of
[January 00, 1900] is in accordance with the Receivables Purchase Agreement
dated July 14, 2005 and that all representations Current Month Current Month 2
4/2/2018 - 12:15 PM

--------------------------------------------------------------------------------